These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 17448198

  • 1. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL, DiMaio DJ.
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S, Mar N, McCalmont TH.
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB, Purohit C, Anglin TR.
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [Abstract] [Full Text] [Related]

  • 4. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA, Brill LB, Patterson JW, Wick MR.
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of CD163 in cutaneous spindle cell lesions.
    Pouryazdanparast P, Yu L, Cutlan JE, Olsen SH, Fullen DR, Ma L.
    J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
    [Abstract] [Full Text] [Related]

  • 6. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN, Dyck R, Weenig RH, Comfere NI.
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [Abstract] [Full Text] [Related]

  • 7. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC, Calder KB, Cibull TL, Thomas AB, Billings SD, Morgan MB, Hiatt KM, Smoller BR.
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [Abstract] [Full Text] [Related]

  • 8. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
    Clarke LE, Frauenhoffer E, Fox E, Neves R, Bruggeman RD, Helm KF.
    J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B, Hofmann-Wellenhof R, Kaddu S, McCalmont TH.
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myxoid atypical fibroxanthoma: a previously undescribed variant.
    Patton A, Page R, Googe PB, King R.
    J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
    Attis MG, Burchette JL, Selim MA, Pham T, Soler AP.
    Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT, Selim MA, Burchette JL, Madden J, Turner J, Herman C.
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.